Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jennifer Tang

1PUBLICATIONS
17CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

Alexandra Schäfer, David R Martinez, John J Won

Pageof 1

Frequent Collaborators

1 joint publications

Alexandra Schäfer

1 joint publications

David R Martinez

1 joint publications

John J Won

1 joint publications

Rita M Meganck

1 joint publications

Kendra L Gully

1 joint publications

Stephanie Dong

1 joint publications

Darius Babusis

1 joint publications

Eisuke Murakami

1 joint publications

Kimberly T Barrett

1 joint publications

Blake J Bleier

Frequent Collaborators

1 joint publications

Alexandra Schäfer

1 joint publications

David R Martinez

1 joint publications

John J Won

1 joint publications

Rita M Meganck

Top Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.5K
See more related videos

Top Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.5K
See more related videos